$68.2 Million is the total value of Trustees of Columbia University in the City of New York's 16 reported holdings in Q2 2023. The portfolio turnover from Q1 2023 to Q2 2023 was 100.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| EVLO | Exit | EVELO BIOSCIENCES INC | $0 | – | -113,850 | -100.0% | -0.04% | – |
| AVTE | Exit | AEROVATE THERAPEUTICS INC | $0 | – | -13,190 | -100.0% | -0.48% | – |
| TDG | Exit | TRANSDIGM GROUP INC | $0 | – | -3,103 | -100.0% | -4.09% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2023-08-14
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| BERKSHIRE HATHAWAY INC DEL | 9 | Q4 2023 | 87.0% |
| RAPT THERAPEUTICS INC | 9 | Q4 2023 | 3.8% |
| BERKSHIRE HATHAWAY INC DEL | 9 | Q4 2023 | 0.8% |
| VOR BIOPHARMA INC | 8 | Q4 2023 | 9.6% |
| TENAYA THERAPEUTICS INC | 6 | Q4 2023 | 9.2% |
| EVELO BIOSCIENCES INC | 6 | Q1 2023 | 2.3% |
| SURROZEN INC | 6 | Q4 2023 | 0.1% |
| VIGIL NEUROSCIENCE INC | 5 | Q4 2023 | 5.0% |
| SURROZEN INC | 5 | Q3 2023 | 7.8% |
| XILIO THERAPEUTICS INC | 5 | Q4 2023 | 1.4% |
View Trustees of Columbia University in the City of New York's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-13 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-14 |
| 13F-HR | 2023-05-15 |
| 13F-HR | 2023-02-15 |
| 13F-HR | 2021-11-15 |
| 13F-HR | 2021-08-16 |
| 13F-HR | 2021-05-17 |
| 13F-HR | 2021-02-16 |
View Trustees of Columbia University in the City of New York's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.